Share-based Payment Arrangements | (3) Share-based Payment Arrangements As of June 30, 2018, the Company had two employee equity incentive plans, the 2002 employee stock option and stock incentive plan (the “ESOSIP”) and the 2011 equity incentive plan (the “2011 EIP”). No further grants can be made under the ESOSIP. The Company also has a stock compensation plan for members of its Board of Directors, the Amended and Restated 2013 Directors Stock Compensation Plan (as amended and restated as of May 17, 2016, the “2013 DSCP”). 6,000,000 shares of the Company’s common stock were authorized for issuance under the 2011 EIP and 115,000 shares of the Company’s common stock were authorized for issuance under the 2013 DSCP. The ESOSIP, 2011 EIP and 2013 DSCP are each referred to herein as a “Plan,” and, collectively, as the “Plans.” Amounts recognized in the financial statements with respect to these Plans are as follows (in thousands): Twenty Six Weeks Ended Thirteen Weeks Ended June 30, 2018 July 1, 2017 June 30, 2018 July 1, 2017 Total cost of the Plans during the period $ 8,102 $ 2,237 $ 4,392 $ 1,243 Amount of related income tax benefit recognized during the period (3,468 ) (1,814 ) (1,217 ) (687 ) Net cost of the Plans during the period $ 4,634 $ 423 $ 3,175 $ 556 Included in income tax benefits recognized in the twenty-six-week twenty-six-week As of June 30, 2018, there were 72,742 shares of the Company’s common stock reserved for issuance under the 2013 DSCP and 4,486,031 shares of the Company’s common stock reserved for issuance in the aggregate under the ESOSIP and 2011 EIP. Restricted Stock Units The following table summarizes information regarding the Company’s outstanding restricted stock unit (“RSU”) awards with either a performance condition or a market condition under the Plans: Number of Weighted Average Grant Date Fair Value Outstanding at December 30, 2017 387,372 $ 55.75 Granted 65,228 $ 96.20 Vested (67,971 ) $ 53.92 Forfeited (92,880 ) $ 52.36 Outstanding at June 30, 2018 291,749 $ 66.30 During the twenty-six-week 10-K. RSUs with a performance condition granted on February 2, 2018 may vest on January 31 of 2021, 2022 and 2023 based on growth in operating income and pre-tax On April 24, 2018, the Company granted 9,324 RSUs that vest based on a market condition. These RSUs may vest on June 30 of 2022, 2023 and 2024 based on the Company’s total shareholder return (“TSR”) compound annual growth rate over the vesting periods, adjusted to reflect dividends (if any) paid during such periods and capital adjustments as may be necessary. The maximum number of common shares available for issuance under the April 24, 2018 grant equals 150% of the number of RSUs granted. The fair value of this RSU award was determined at the time of grant based on the expected achievement of the market condition at the end of each vesting period. With respect to these RSU awards, the Company reports compensation expense ratably over the life of the award based on an estimated number of units that will vest over the life of the award, multiplied by the fair value of the RSU. Previously recognized compensation cost would be reversed only if the employee terminated employment prior to completing the requisite service period. The Company recognized approximately $6,975,000 and $1,309,000 of share-based compensation expense related to RSU awards in the twenty-six-week Stock Options The following table summarizes information regarding the Company’s outstanding stock options under the Plans: Weighted Average Number of Weighted Average Remaining Aggregate Intrinsic Options per Share Term (years) Value (000s) Options outstanding at December 30, 2017 189,040 $ 49.34 Exercised (51,918 ) $ 48.52 Options outstanding at June 30, 2018 137,122 $ 49.64 3.5 $ 8,166 Options exercisable at June 30, 2018 136,122 $ 49.58 3.5 $ 8,115 The total intrinsic value of stock options exercised during the twenty-six-week As of June 30, 2018, there was no unrecognized compensation cost related to non-vested Non-vested The following table summarizes information regarding the Company’s outstanding shares of non-vested Number of Shares and Deferred Stock Weighted Average Grant Date Fair Value Non-vested 54,755 $ 78.02 Granted 22,803 $ 113.35 Vested (19,162 ) $ 74.42 Forfeited (1,757 ) $ 71.12 Non-vested 56,639 $ 93.68 The fair value of each share of non-vested non-vested As of June 30, 2018, there was $4,327,000 of total unrecognized compensation cost related to non-vested non-vested |